Brazzoli M - Search Results

1

Positive Contribution of Adjuvanted Influenza Vaccines to the Resolution of Bacterial Superinfections.

Zurli V, Gallotta M, Taccone M, Chiarot E, Brazzoli M, Corrente F, Bonci A, Casini D, De Gregorio E, Baudner BC, Bertholet S, Seubert A. Zurli V, et al. Among authors: brazzoli m. J Infect Dis. 2016 Jun 15;213(12):1876-85. doi: 10.1093/infdis/jiw048. Epub 2016 Feb 9. J Infect Dis. 2016. PMID: 26908732

2

Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice.

Hekele A, Bertholet S, Archer J, Gibson DG, Palladino G, Brito LA, Otten GR, Brazzoli M, Buccato S, Bonci A, Casini D, Maione D, Qi ZQ, Gill JE, Caiazza NC, Urano J, Hubby B, Gao GF, Shu Y, De Gregorio E, Mandl CW, Mason PW, Settembre EC, Ulmer JB, Craig Venter J, Dormitzer PR, Rappuoli R, Geall AJ. Hekele A, et al. Among authors: brazzoli m. Emerg Microbes Infect. 2013 Aug;2(8):e52. doi: 10.1038/emi.2013.54. Epub 2013 Aug 14. Emerg Microbes Infect. 2013. PMID: 26038486 Free PMC article.

3

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.

Brazzoli M, Magini D, Bonci A, Buccato S, Giovani C, Kratzer R, Zurli V, Mangiavacchi S, Casini D, Brito LM, De Gregorio E, Mason PW, Ulmer JB, Geall AJ, Bertholet S. Brazzoli M, et al. J Virol. 2015 Oct 14;90(1):332-44. doi: 10.1128/JVI.01786-15. Print 2016 Jan 1. J Virol. 2015. PMID: 26468547 Free PMC article.

4

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.

Magini D, Giovani C, Mangiavacchi S, Maccari S, Cecchi R, Ulmer JB, De Gregorio E, Geall AJ, Brazzoli M, Bertholet S. Magini D, et al. Among authors: brazzoli m. PLoS One. 2016 Aug 15;11(8):e0161193. doi: 10.1371/journal.pone.0161193. eCollection 2016. PLoS One. 2016. PMID: 27525409 Free PMC article.

5

Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines.

Manara C, Brazzoli M, Piccioli D, Taccone M, D'Oro U, Maione D, Frigimelica E. Manara C, et al. Among authors: brazzoli m. Vaccine. 2019 Jul 9;37(30):4204-4213. doi: 10.1016/j.vaccine.2019.04.028. Epub 2019 Jun 18. Vaccine. 2019. PMID: 31227353

6

Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines.

Goswami R, Chatzikleanthous D, Lou G, Giusti F, Bonci A, Taccone M, Brazzoli M, Gallorini S, Ferlenghi I, Berti F, O'Hagan DT, Pergola C, Baudner BC, Adamo R. Goswami R, et al. Among authors: brazzoli m. ACS Infect Dis. 2019 Sep 13;5(9):1546-1558. doi: 10.1021/acsinfecdis.9b00084. Epub 2019 Jul 23. ACS Infect Dis. 2019. PMID: 31290323 Free article.

7

Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines.

Anderluzzi G, Lou G, Gallorini S, Brazzoli M, Johnson R, O'Hagan DT, Baudner BC, Perrie Y. Anderluzzi G, et al. Among authors: brazzoli m. Vaccines (Basel). 2020 May 8;8(2):212. doi: 10.3390/vaccines8020212. Vaccines (Basel). 2020. PMID: 32397231 Free PMC article.

8

Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.

Lou G, Anderluzzi G, Schmidt ST, Woods S, Gallorini S, Brazzoli M, Giusti F, Ferlenghi I, Johnson RN, Roberts CW, O'Hagan DT, Baudner BC, Perrie Y. Lou G, et al. Among authors: brazzoli m. J Control Release. 2020 Sep 10;325:370-379. doi: 10.1016/j.jconrel.2020.06.027. Epub 2020 Jul 1. J Control Release. 2020. PMID: 32619745 Free article.

9

The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.

Anderluzzi G, Lou G, Woods S, Schmidt ST, Gallorini S, Brazzoli M, Johnson R, Roberts CW, O'Hagan DT, Baudner BC, Perrie Y. Anderluzzi G, et al. Among authors: brazzoli m. J Control Release. 2022 Feb;342:388-399. doi: 10.1016/j.jconrel.2021.12.008. Epub 2021 Dec 10. J Control Release. 2022. PMID: 34896446 Free PMC article.

10

Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response.

Siena E, Schiavetti F, Borgogni E, Taccone M, Faenzi E, Brazzoli M, Aprea S, Bardelli M, Volpini G, Buricchi F, Sammicheli C, Tavarini S, Bechtold V, Blohmke CJ, Cardamone D, De Intinis C, Gonzalez-Lopez A, O'Hagan DT, Nuti S, Seidl C, Didierlaurent AM, Bertholet S, D'Oro U, Medini D, Finco O. Siena E, et al. Among authors: brazzoli m. Vaccine. 2023 Jan 16;41(3):724-734. doi: 10.1016/j.vaccine.2022.12.006. Epub 2022 Dec 21. Vaccine. 2023. PMID: 36564274 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page